San Diego – September 22, 2026 -- Circular Genomics and Altoida have entered a collaboration pairing blood-based circular RNA (circRNA) biomarkers with AI-powered digital cognitive testing to accelerate Alzheimer's drug development and build a scalable frontline diagnostic pathway.

Norwalk, Conn. – September 22, 2026 -- Heartwood Partners has made a growth investment in The Xtreme Group (TXG), a Miami-based aviation MRO platform, in partnership with the company's existing management team, the private equity firm announced. The transaction closed on May 29, 2026.

Los Angeles – September 22, 2026 -- Composition Wealth, a registered investment advisor managing more than $12 billion in assets, has appointed Gabrielle Glemann as General Counsel and Chief Compliance Officer and Joe Salcido as Head of Advisors, adding two executives with a combined 40 years of industry experience to its 125-employee national platform.

Calgary – September 22, 2026 -- Forty-one percent of adults under 45 in the U.S. and Canada now pay for services that family and friends once provided, more than double the 18% reported by adults aged 62-80, according to a new study from Cashew Research.

Greenwich, Conn. – – September 22, 2026 -- Hunt Scanlon Ventures, an M&A advisory firm focused on human capital markets, has completed an investment in millionways, a New York-based AI lab building what it calls a behavioral intelligence layer for artificial intelligence systems.

Las Vegas – September 22, 2026 -- Hyperscale Data, Inc. (NYSE American: GPUS) is moving to spin off its Bitcoin mining operations into a new subsidiary, Patriot BTC, separating the business from the company's Michigan AI data center strategy.

Santa Clara, Calif. – September 22, 2026 -- Aeonsemi, Inc. has introduced the Praxium PHY family, a line of multi-gigabit Ethernet transceivers delivering data rates up to 10 Gbps in a 6 x 6 mm QFN package for robots, autonomous vehicles and industrial machines.

San Francisco – September 22, 2026 -- Owl Ventures, the world's largest venture capital firm focused on education and workforce innovation, has named NBA legend Chris Paul as Venture Partner, adding a high-profile figure to a firm managing more than $2.2 billion in committed capital.

Holon, Israel – September 22, 2026 -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) will host a virtual key opinion leader event on October 5, 2026 at 8:00 AM ET, presenting new detail on COM701, its anti-PVRIG antibody candidate for relapsed platinum-sensitive ovarian cancer (PSOC).

Boulder, Colorado – September 22, 2026 -- Edgewise Therapeutics (Nasdaq: EWTX) disclosed preclinical data showing its lead cardiac drug candidate EDG-7500 improves heart relaxation while preserving systolic function, a mechanism the company says addresses a core driver of hypertrophic cardiomyopathy (HCM) that current therapies do not fully target.